CClinicalTrials.gg
RecruitingNCT06076967Updated Aug 12, 2024

Mindfulness Intervention for College Students With ADHD

An interventional study of Mindfulness Awareness Practices for ADHD (adapted) and Services-As-Usual in Attention Deficit Hyperactivity Disorder, sponsored by University of Alabama, Tuscaloosa. Recruiting at 2 sites in United States. Open to participants aged 17 Years to 25 Years. Per ClinicalTrials.gov, last updated 2024-08-12.

Sponsored by University of Alabama, Tuscaloosa · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
100
Allocation
Randomized
Ages
17 Years to 25 Years
Sex
All
01

Study summary

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder that commonly persists into adulthood and is associated with significant life impairments. The current study evaluates the feasibility, acceptability, and preliminary efficacy of a group-based mindfulness intervention for first-year college students with ADHD. If found to be feasible, acceptable, and efficacious, subsequent research will examine its impact on a larger scale to have a broader public health impact for college students with ADHD.

Read the detailed description

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder that commonly persists into adulthood. Stimulant and non-stimulant pharmacotherapies are the mainstay of treatment; however, non- pharmacological interventions such as mindfulness have significant empirical support. The Mindful Awareness Practices (MAPs) for ADHD program, an 8-week, group-based mindfulness program for adults with ADHD, has been shown to reduce ADHD, depression, and anxiety symptoms. While promising, it is unknown as to whether the MAPs protocol is feasible, acceptable, and efficacious for college students with ADHD. The current study takes the first step towards enhanced study of mindfulness for college students with ADHD by testing the feasibility, acceptability, and preliminary efficacy of an adapted MAPs protocol delivered within university counseling center settings during the first semester of college. First-year college students with ADHD will be recruited at the University of Alabama and Wofford College. After developing and beta testing an adapted MAPs intervention at both sites, students will be randomized to adapted MAPs or Services-As-Usual (SAU; standard support services provided by the universities). Groups will include 10 first-year students and will be run over a 2-year period in the fall semesters (i.e., 4 MAPs groups across the two sites; total MAPs n = 40; total SAU n = 40). MAPs groups will be led by trained therapists in university counseling centers. Assessments will occur at pre, post, and 6-month follow-up using measures of ADHD, sluggish cognitive tempo (SCT), anxiety, and depression symptoms along with emotion regulation and mindfulness, our hypothesized mechanisms of change. Aims of the project are to: 1) adapt, manualize, and beta test the intervention, 2) conduct a pilot randomized controlled trial of adapted MAPs compared to SAU and examine feasibility and acceptability measures and clinical outcomes, and 3) examine whether the adapted MAPs intervention changes the targets hypothesized to be associated with changes in clinical outcomes (i.e., emotional regulation, mindfulness). If adequate feasibility, acceptability, and preliminary efficacy are documented, mindfulness for college students with ADHD can continue to be evaluated in larger trials. If ultimately found to be efficacious, this protocol has the potential to be widely disseminated within college counseling centers to have a broader public health impact for college students with ADHD.

02

Conditions studied

  • Attention Deficit Hyperactivity Disorder

Keywords

  • ADHD
  • Mindfulness
  • College students
  • Emerging adults
03

Who can participate

Ages eligible
17 Years to 25 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • First-semester college student with ADHD
  • Age 17-25
  • Must meet criteria for ADHD
  • No major medical problems

Exclusion criteria

Exclusion Criteria:

  • Severe depression
  • Mania
  • Ongoing substance abuse
  • Personality disorder that may interfere with group delivery
  • Psychotic symptoms
  • Recent history of trauma
  • Unstable dosage of psychotropic medication
04

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
100 participants (estimated)

Study arms

  • Experimental
    Adapted Mindful Awareness Practices (MAPS)

    The Mindful Awareness Practices (MAPs) for ADHD program, an 8-week, group-based mindfulness program for adults with ADHD, has been shown to reduce ADHD, depression, and anxiety symptoms. While promising, it is unknown as to whether the MAPs protocol is feasible, acceptable, and efficacious for college students with ADHD. The current study takes the first step towards enhanced study of mindfulness for college students with ADHD by testing the feasibility, acceptability, and preliminary efficacy of an adapted MAPs protocol delivered within university counseling center settings during the first semester of college.

    Behavioral: Mindfulness Awareness Practices for ADHD (adapted)

  • Active comparator
    Services-As-Usual

    Services-As-Usual includes the standard academic support services provided by university disability/accessibility offices.

    Behavioral: Services-As-Usual

Interventions

  • BehavioralMindfulness Awareness Practices for ADHD (adapted)

    The Mindful Awareness Practices (MAPs) for ADHD program is an 8-week, group-based mindfulness program for adults with ADHD.

  • BehavioralServices-As-Usual

    Services-As-Usual includes the standard support services provided by universities

05

What researchers measure

Primary outcomes

  1. Conners Adult ADHD Rating Scale

    This measure assesses adult ADHD symptoms

    Time frame: Pre-treatment, up to 1-month post-treatment, 6-month follow-up

  2. Adult Concentration Inventory

    This measure assesses adult sluggish cognitive tempo (SCT) symptoms

    Time frame: Pre-treatment, up to 1-month post-treatment, 6-month follow-up

  3. Depression Anxiety Stress Scale-21

    This measure assesses adult anxiety and depression symptoms

    Time frame: Pre-treatment, up to 1-month post-treatment, 6-month follow-up

  4. Difficulties in Emotion Regulation Scale

    This measure assesses emotion regulation abilities in adults.

    Time frame: Pre-treatment, up to 1-month post-treatment, 6-month follow-up

  5. Trier Social Stress Test

    This measure assesses the ability to regulate social stress in a laboratory paradigm.

    Time frame: Pre-treatment, up to 1-month post-treatment, 6-month follow-up

  6. Mind Excessively Wandering Questionnaire

    This measure assesses mind wandering in adults.

    Time frame: Pre-treatment, up to 1-month post-treatment, 6-month follow-up

  7. Five-Facet Mindfulness Questionnaire

    This measure assesses mindfulness in adults.

    Time frame: Pre-treatment, up to 1-month post-treatment, 6-month follow-up

  8. Sustained Attention to Response Task

    This task measures the ability to sustain attention and mind wandering during task performance.

    Time frame: Pre-treatment, up to 1-month post-treatment, 6-month follow-up

  9. Attention Network Task

    This task measures aspects of attention such as alerting, orienting, and executive control.

    Time frame: Pre-treatment, up to 1-month post-treatment, 6-month follow-up

Secondary outcomes

  1. Behavior Rating Inventory of Executive Function - Adult Version

    This measure assesses self-rated executive functioning deficits in adults.

    Time frame: Pre-treatment, up to 1-month post-treatment, 6-month follow-up

  2. Social Functioning Questionnaire

    This measure assesses aspects of social functioning in adults.

    Time frame: Pre-treatment, up to 1-month post-treatment, 6-month follow-up

  3. Grade Point Average

    This measure assess academic performance in the college setting.

    Time frame: 6-month follow-up

Other outcomes

  1. Treatment Satisfaction and Acceptability Questionnaire

    This measure will assess participant satisfaction with the treatment.

    Time frame: Up to 1-month post-treatment

  2. Session Checklist and Therapist Feedback Form

    This measure will assess whether the therapist delivered each intervention component and will ask the therapist to rate the degree of difficulty with implementation.

    Time frame: Weekly during treatment

  3. Implementation Quality Measure

    This measure will involve a rating of how well the therapist implemented therapy session procedures.

    Time frame: Weekly sessions will be rated

06

Study locations

2 of 2 sites recruiting
  • Department of Psychology, University of Alabama
    Tuscaloosa, Alabama 35487, United States
    • Matthew A Jarrett, PhD · Contact · majarrett@ua.edu · 205-348-5083
    • Matthew A Jarrett, PhD · Principal investigator
    Recruiting
  • Department of Psychology, Wofford College
    Spartanburg, South Carolina 29303-3663, United States
    • Dane C Hilton, PhD · Contact · hiltondc@wofford.edu · 864-597-4642
    • Dane C Hilton, PhD · Principal investigator
    Recruiting
07

References and documents

Individual participant data

Plan to share: Yes — Data will be submitted to the National Institute of Mental Health (NIMH) Data Archive

Supporting information: Study protocol, Sap, Icf

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT06076967
Lead sponsor
University of Alabama, Tuscaloosa
Collaborators
Wofford College
Responsible party
Sponsor
First posted
Oct 11, 2023
Start date
Sep 15, 2023
Primary completion
May 15, 2026 (estimated)
Completion
Jul 31, 2026 (estimated)
Last update
Aug 12, 2024

Study contacts

Matthew A Jarrett, PhD
Contact
majarrett@ua.edu
205-348-5083

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion